Variations in DNA Subtype, Antifungal Susceptibility, and Slime Production Among Clinical Isolates of Candida Parapsilosis

Diagn Microbiol Infect Dis. 1995 Jan;21(1):9-14. doi: 10.1016/0732-8893(94)00114-c.

Abstract

Candida parapsilosis is an important nosocomial pathogen that can proliferate in high concentrations of glucose and form biofilms on prosthetic materials. We investigated the genotypic diversity, slime production, and antifungal susceptibility among 60 isolates of C. parapsilosis from 44 patients and 10 patient care providers from five different medical centers. Molecular typing was performed using macrorestriction digest profiles with BssHII followed by pulsed-field gel electrophoresis (REAG) and by electrophoretic karyotyping (EK). Slime production was evaluated by growing the organisms in Sabouraud broth with 8% glucose and examining the walls of the tubes for the presence of an adherent slime layer. Antifungal susceptibility to amphotericin B, 5-fluorocytosine, fluconazole, and itraconazole was determined using National Committee for Clinical Laboratory Standards proposed standard methods. Overall 28 different DNA types were identified by REAG and EK methods. MIC90 values ranged from 0.12 microgram/ml for itraconazole to 1.0 microgram/ml for fluconazole and amphotericin B. Sixty-five percent of the isolates produced slime: 37% were moderately to strongly positive, 28% were weakly positive, and 35% were negative. Overall, 83% of blood and catheter isolates were slime positive versus 53% of isolates from all other sites (P < 0.05). These data underscore the genetic diversity and susceptibility of C. parapsilosis to antifungal agents. Slime production may be important in enabling C. parapsilosis to cause catheter-related bloodstream infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology
  • Candida / drug effects*
  • Candida / genetics*
  • Candida / metabolism
  • Candidiasis / epidemiology
  • Candidiasis / microbiology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • DNA, Fungal / isolation & purification*
  • Fluconazole / pharmacology
  • Flucytosine / pharmacology
  • Humans
  • Itraconazole / pharmacology
  • Karyotyping
  • Microbial Sensitivity Tests
  • Molecular Epidemiology

Substances

  • DNA, Fungal
  • Itraconazole
  • Amphotericin B
  • Fluconazole
  • Flucytosine